Clinical application of thrombus aspirated catheter(DIVERTM)in primary PCI for acute myocardial infarction

吴建国,张伶,卢清玉,常宇锋,耿学峰,余阳

DOI: https://doi.org/10.3969/j.issn.1004-8812.2007.02.003

2007-01-01

Abstract:Objective To evaluate the clinical effect and safety of the thrombus aspirated catheter (DIVER~(TM)) in primary PCI for acute myocardial infarction. Methods Seventy four AMI patients with total occluded infarct-related coronary artery(IRA)and intra-coronary thrombus from March 2005 to April 2006 were divided into two groups according to admission time and the treatment they received. After the 0.014 in BMW coronary wire crossed the lesion, the thrombus aspirated catheter (DIVERTM) was advanced over the wire to the lesion and continuously aspirated 2-3 times until the thrombus disappeared and stents were directly implanted in patients in group A (n=36) admitted from December 2005 to April 2006. Routine PCI applied in patients in group B (n=38) admitted from March 2005 to December 2005. Sirolimus eluting stents were implanted in both groups. The artery re-opened rate, no-reflow rate and the rate of major adverse cardiac events during hospitalization and 6 months after discharge were compared between two groups. Results Coronary arteriography showed the artery re-opened rate was 100% in both groups. The rates of no-reflow and major adverse cardiac events during hospital stay were significantly lower in group A than those in group B (2.78% vs 21.05% and 2.78% vs 10.53% respectively,P0.05). Within the post-discharge follow-up of 6 months, the rate of major adverse cardiac events remained nill in both groups. Conclusion Compared with routine therapy, the application of thrombus aspirated catheter (DIVER~(TM)) in primary PCI for acute myocardial infarction was feasible and provided better clinical efficacy.